Fact Meets Function

This review article examined nicotinamide mononucleotide (NMN) supplementation and the metabolic variability observed in response to NMN treatment across different populations and conditions. The review found that individual differences in NAD+ metabolism, age, genetic factors, and baseline metabolic status significantly influence how people respond to NMN supplementation, with implications for personalizing potential therapeutic applications. **Evidence level: Review article** (synthesizes existing literature rather than presenting original human clinical or experimental data).

This review article examined the role of nicotinamide mononucleotide (NMN) in aging processes and explored potential biological mechanisms through which NMN may influence age-related changes (Review). The authors synthesized evidence suggesting NMN acts as a NAD+ precursor that may affect cellular energy metabolism, mitochondrial function, sirtuins, and DNA repair pathways implicated in aging.

This review article examined nicotinamide mononucleotide (NMN) as a potential anti-aging intervention, evaluating both its proposed benefits and safety profile across available evidence. The authors identified promises in preclinical models and limited human data regarding metabolic and cardiovascular effects, while also highlighting gaps in long-term safety data and regulatory oversight for NMN as a commercial health product. This is a **review article** synthesizing existing literature rather than original human clinical research.

This review article examined the potential benefits and risks of NAD+ (nicotinamide adenine dinucleotide) therapeutic approaches, including NMN supplementation, across age-related degenerative diseases by analyzing existing clinical and preclinical evidence. The authors assessed both the rationale for NAD+ augmentation in aging-related conditions and identified potential safety concerns requiring consideration in therapeutic development. This is a **review article** synthesizing existing human clinical, animal model, and in vitro research rather than original research data.

This review article examines the relationship between aging, homeostasis disruption, and age-associated diseases, with a focus on nicotinamide mononucleotide (NMN) as a potential clinical application (evidence level: review). The authors discuss how aging affects the body’s ability to maintain homeostasis and how this contributes to the development of chronic diseases, while exploring NMN’s proposed mechanisms in potentially addressing age-related physiological decline. The review synthesizes existing literature on NMN’s role in cellular energy metabolism and NAD+ restoration as it relates to aging and disease management.